A major cause of chemoresistance and recurrence in tumors is the presence of dormant tumor foci that survive chemotherapy and can eventually transition to active growth to regenerate the cancer. In this paper, we propose a Quasi Birth-and-Death (QBD) model for the dynamics of tumor growth and recurrence/remission of the cancer. Starting from a discrete-state master equation that describes the timedependent transition probabilities between states with different numbers of dormant and active tumor foci, we develop a framework based on a continuum-limit approach to determine the time-dependent probability that an undetectable residual tumor will become large enough to be detectable. We derive an exact formula for the probability of recurrence at large times and show that it displays a phase transition as a function of the ratio of the death rate µ A of an active tumor focus to its doubling rate λ. We also derive forward and backward Kolmogorov equations for the transition probability density in the continuum limit and, using a first-passage time formalism, we obtain a drift-diffusion equation for the mean recurrence time and solve it analytically to leading order for a large detectable tumor size N . We show that simulations of the discretestate model agree with the analytical results, except for O(1/N ) corrections. Finally, we describe a scheme to fit the model to recurrence-free survival (Kaplan-Meier) curves from clinical cancer data, using ovarian cancer data as an example. Our model has potential applications in predicting how changing chemotherapy schedules may affect disease recurrence rates, especially in cancer types for which no targeted therapy is available.
Introduction
The advent of chemotherapy was an important milestone in the history of cancer treatment and research.
For the treatment of early stage cancer, it remains the only option after surgery and radiation for cancers where no long-term targeted adjuvant (post-surgery) therapy is available, such as serous ovarian cancer and triple negative (ER-/HER2-/PR-) breast cancer [1] . By targeting rapidly cycling cells, chemotherapy 5 systemically attacks growing tumors. Side effects on other tissues, especially on cells with a high turnover rate, such as skin and the intestinal epithelium, can be moderate to severe, depending on the duration and intensity of treatment.
Several mathematical models have been proposed to predict optimal regimens of adjuvant chemotherapy to specify duration, dosage levels or dosing protocols, with the goal of reducing recurrence hazard rates. 10 These models may be classified by their mathematical approach, which can be either stochastic or deterministic and linear or nonlinear, and to the nature of the biological assumptions underlying them (see [2] for a review). Examples of such models include optimal-control-theory models [3] , game-theoretical models [4] , as well as models of drug resistance and/or chemotherapy scheduling, which can be either stochastic [5] [6] [7] [8] or deterministic [9] [10] [11] . 15 In current clinical practice, chemotherapy is usually given at "maximum tolerated dose" for the "minimum possible duration", which is usually 3-6 months, in the belief that this will have the most benefit to the patient in the least possible time [13] . This is based on modeling tumor cells as continuously dividing at some fixed deterministic rate [14] . Norton and Simon [15] proposed that tumor growth follows a type of sigmoid curve known in the literature as the Gompertzian function, and also proposed the tumor-regression 20 hypothesis, that cell kill is proportional to the growth rate of the untreated tumor [12, 16] . Since the Gompertzian growth rate decreases as the tumor grows, they concluded that it becomes increasingly more difficult to kill the tumor as its size increases. This model provides the justification for the "maximum tolerated dose" and maximizing dose density, the goal being to efficiently kill the tumor when it is small and growing rapidly. However, the effectiveness of this treatment paradigm is unclear and not entirely consistent 25 with some clinical and experimental data [17, 18] (see also the review paper [16] for a detailed literature review).
Furthermore, it is known that the stage of a cancer, which is related to the tumor size and degree of lymph node involvement, is an excellent predictor of prognosis, independently of cancer type or therapy.
The larger the tumor, the more difficult it is to effect a cure. Likewise, tumor grade, which is a measure of 30 tumor aggressiveness, is also a good predictor of outcome. However, it has been suggested that the fractional impact of treatment on improved survival is higher for patients with late-stage or high-grade tumors than for patients with early-stage or low-grade tumors (see, for example, the studies [20] and [21] ). This observation argues against the high-dose/short-term treatment paradigm by suggesting that unlike Norton and Simon proposed in their deterministic Gompertzian growth model, tumor cells may not all be in continuous growth, and that actively growing tumors tend to be more responsive to cytotoxic drugs than those that are mostly in a dormant or resting state.
In [19] , a stochastic alternative to Norton and Simon's deterministic Gompertzian model is proposed for breast cancer, where tumors are not in continuous growth, but can be either in a dormant state or in an active-growth state. Indeed, it has been suggested that a major cause of resistance to chemotherapy is the 40 presence of dormant tumor foci with a cycle time that exceeds the duration of chemotherapy [18, 19, 22] . This is consistent with the observation that often, the effect of chemotherapy on recurrence rates does not last for a long time after chemotherapy ends. Several clinical trials [23] [24] [25] have shown that improved recurrence rates for patients receiving chemotherapy revert to rates for the control group (who received no chemotherapy) in a relatively short time after termination of treatment, suggesting the presence of residual 45 dormant tumor foci that survive treatment and regenerate the cancer. These data also suggest that shortduration chemotherapy only targets the tumor foci that cycle during chemotherapy. Tumor foci that cycle after chemotherapy ends are not affected and can cause recurrence. This suggests that chemotherapy may be more effective if its duration is optimized to the time it takes dormant foci to transition to active growth.
Direct evidence for this hypothesis is available in analysis of lymphoma data [26, 27] , where maximiz- 50 ing chemotherapy dosage did not have a prolonged effect on outcome, whereas extending the duration of chemotherapy, while maintaining a minimum effective dose was more beneficial. Long-term hormonal therapy with drugs that target the ER pathway (e.g. tamoxifen) in ER+/HER2-breast cancers, which are low grade (have low transition rates of tumor foci from dormancy to active growth) provides yet another example that longer-term treatment is preferable to short-term treatment [28] . These studies provide evi- 55 dence that optimally adjusting the duration of chemotherapy may improve chemotherapy effectiveness, while maintaining the same total amount of drug administered over the course of the chemotherapy regimen.
These observations suggest the following two hypotheses: 1) For a given cancer type, there is a characteristic time for dormant tumor foci to transition to active growth; 2) Dormant tumor foci are often resistant to chemotherapeutic agents, while active tumor foci are not. Based on these hypotheses, we develop a math-60 ematical model and framework with potential application to study the impact of variation in dosage and duration of chemotherapy on recurrence rates. Our model may serve as a guide for the design of experiments and clinical trials that may eventually lead to optimized chemotherapy regimens.
The remainder of the paper is organized as follows. In Section 2, we give an overview of the model by defining its state space, parameters and transition rules. In Section 3, the stochastic dynamics of the During chemotherapy (between time t = 0 and time t = t chemo > 0), the death rate is µ A = µ chemo and after treatment (beyond time t = t chemo ), it decreases to a lower baseline rate µ A = µ 0 .
• By definition, a dormant (D) tumor focus cannot double, but it could in principle die at some rate 105 µ D . However, we will eventually set µ D = 0. This is because dormant foci can repair chemotherapy damage as we argued above, i.e., they are chemoresistant.
• An active (A) tumor focus may transition to dormancy (D) at rate ξ and a dormant tumor focus may become active at rate η.
• LetT D andT A be the respective times that a tumor focus spends, on average, in the dormant and active states before it doubles (averaged over many doublings). It then follows that the D → A and A → D hopping rates are given by η = 1/T D and ξ = 1/T A , respectively, so the doubling rate is given by λ = 1/(T A +T D ). Hence, the rates η, ξ and λ are related by the equation
This constraint reduces the number of parameters in the model by one and allows us to parametrize the rates η, ξ as
• All the tumor foci within each population (either D or A) are equally likely to undergo a transition, so each transition probability on the two-dimensional lattice of states is proportional to either the population of dormant foci (m) or the population of active foci (n). The transition probabilities of any transitions beyond nearest neighbors are assumed to be second order in infinitesimal time, so the model is "skip free". The transition probabilities to neighboring states are then given by
Pr{m − 1, n + 1; t + ∆t|m, n; t} = ηm∆t + O(∆t 2 )
and for transitions to states beyond nearest-neighbors, i.e., for |m − m | > 1 or |n − n | > 1, we assume Pr{m , n ; t + ∆t|m, n; t} = O(∆t 2 ).
A diagram of the state space showing the transitions above is given in Fig. 1 .
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• If the total number of tumor foci m + n reaches a sufficiently large number N , the tumor becomes detectable and no further transitions are allowed, i.e., the disease recurrence is defined by means of absorbing boundary conditions at the recurrence boundary m + n = N . The absorbing boundary condition at the extinction state (0, 0) is automatically satisfied, since the transition rates are proportional to either m or n. 115 
Master equation for the state probabilities
From the transition rules described in Section 2, it follows that the time evolution of the state probabilities p mn (t) is given by the master equation
where |p(t) is the probability vector, whose components are the state probabilities p mn (t), i.e., |p(t) = mn p mn (t) |m, n . The infinitesimal transition operatorQ =Q bulk +Q edge consists of a "bulk" partQ bulk and an edge correctionQ edge due to the absorbing boundary conditions at the recurrence line m + n = N .
In second-quantized language, the bulk part is given bŷ
and the edge correction is given bŷ
In Eq. (7),d + andd − are respectively creation and annihilation operators for dormant tumor foci and a + andâ − are those for the active foci. These operators are defined as:
The number operatorsm andn are defined in the usual fashion:
m |m, n = m |m, n , n |m, n = n |m, n .
The structure of the matrixQ is block-tridiagonal in the linear space D ⊗ A, with block indices (m, m ) that run across the Fock states of D, and with indices (n, n ) within each nonzero block that run across the Fock states of A. The N + 1 blocks along the diagonal are themselves tridiagonal and decrease in size as the D-space index n increases. The structure ofQ, as described in Appendix A, is sufficiently complicated 120 that explicit analytical solutions are not straightforward, although analytical formulas are available for the inversion of general tridiagonal and even certain types of block-tridiagonal matrices [31, 32] . Analytical and even stable numerical methods for general level-dependent QBD processes, i.e., QBD models with a block-tridiagonal matrix structure where the blocks are not constant along the diagonals [33] , are scarce in the literature. Although a matrix-analytic method has been developed for these models in [34] , it still relies 125 on the ability to to solve non-trivial matrix equations. Numerical methods have been developed for finding stationary distributions in level-dependent QBD models [35] , but generally applicable numerical methods for finding transient solutions (other than the expensive matrix exponentiation) have yet to be developed [36] . For a special class of level-dependent QBD models with applications in biology and epidemiology, a method based on a continuous-fraction representation of the Laplace-transformed transition probabilities 130 has recently been developed [36] . However, it is not applicable to the model defined by Eqs. (5), (6) and (7), where all the transition and birth/death rates can be nonzero.
If we disregard constraint (1) for the moment and consider the special case η = ξ = µ D = 0, the system reduces to a continuous-time birth-and-death process with transition rates λn and µ A n (otherwise known in queuing theory as the M/M/1/N queue [29] ) and with absorbing boundary states. The version of this model with N → ∞ (i.e., semi-infinite Markov chain) and reflecting boundary conditions has been studied extensively and analytical solutions have been obtained for its transient analysis using several techniques [37] [38] [39] [40] [41] . A version of the M/M/1/N queuing model that is more relevant to our analysis is the one with finite N and absorbing boundary states, which is solved analytically in [42] , where the transient solution is obtained and a simple expression is given for the large-time probability π rec of absorption at the state n = N (corresponding to recurrence in our model), under the initial condition p n (0) = δ n,n0 :
The probability of absorption at the zero-particle state n = 0 (corresponding to cure) is then π cure = 1 − π rec . In the limit N → ∞, we note that this model has a phase transition at µ A /λ = 1:
As will be shown in Section 5.1, a similar stationary solution also occurs in general in the QBD model defined by Eqs. (5), (6) and (7). We will show this both analytically in the continuum limit and in simulations of the discrete-state stochastic process. There are two alternative ways to represent the time evolution of the stochastic process at hand [43-47], namely the forward master equation (5) and the backward master equation
whereQ † is the adjoint of the operatorQ defined in Eqs. (6), (7) and the state vector P (m, n; t)| is defined as the probability to end up at a particular state m, n| at time t, starting from any state m 0 , n 0 | at time t = 0, i.e., P (m, n; t)| ≡ m0,n0 m 0 , n 0 | Pr{m, n; t|m 0 , n 0 ; 0}.
When either Eq. (5) or Eq. (12) is used in the large-N expansion, we get respectively the forward or the backward Kolmogorov equation in the continuum limit 1/N 1 by truncating the expansion after the second term, as discussed further below.
We can define a continuum limit of the state space Ω = {(m, n)|m ≥ 0; n ≥ 0; m + n ≤ N } by defining continuous variables x = m/N and y = n/N , which represent the dormant and active foci populations as a fraction of the detectable tumor size N , respectively. We define a "tumor focus" as the resolution scale of our model: for example, we can define a focus as 1/1000 of a detectable tumor, in which case N = 1000 is a natural definition of recurrence (detectable tumor size). When N 1, the lattice of discrete states (m, n)
becomes a continuum as the spacings 1/N decrease to zero. The discrete probabilities p mn (t) can then be replaced by a smooth probability density ρ( x, t) = N 2 p mn (t), where x = (x, y) is an arbitrary point in the
We proceed to take the continuum limit of the master equation by first replacing the raising/lowering operators (see Eqs. (5), (6) and (8)) by the corresponding translation operators in the continuum, i.e., d ± → e ∓δx∂/∂x andâ ± → e ∓δy∂/∂y (the reason for the opposite signs is that the creation and annihilation operators are passive transformations, whereas the continuum translation operators are defined as active transformations). Then a Kramers-Moyal expansion of the master equation can be obtained by expanding the operator (6) in powers of δx = δy = 1/N . Retaining only the first and the second terms in this large-size expansion, we obtain the two-dimensional Fokker-Planck equation
which is a local continuity equation with a probability current density given by
where each drift term is a product of the respective transition rate by the probability density, along the unit vector in the direction of the transition, and the terms proportional to 1/N represent diffusion, with 155 a diffusion tensor that involves off-diagonal terms (i.e., the terms that involve mixed second derivatives ∂ 2 ρ/∂x∂y are nonzero) and is dependent upon the state variables (x, y).
Since Eq. (14) gives the probability density ρ( x, t) at any state x = (x, y) at time t ≥ 0, given the initial condition ρ( x, 0), it corresponds to the well-known forward Kolmogorov equation [43] [44] [45] [46] [47] . Here we define the initial condition to be sharply peaked at a state x 0 = (x 0 , y 0 ), i.e., ρ( x, 0) = δ( x − x 0 ). Note that the normalization of the probability density ρ( x, t) is not preserved by the time evolution, because the probability flux exits through the recurrence boundary x + y = 1, and also accumulates at the cure state (0, 0).
The boundary conditions for Eq. (14) are the following. At the recurrence line x + y = 1, the absorbing boundary condition is ρ( x, t) = 0. In the vicinity of the cure state (0, 0) we define ρ( x, t) = 0 on the line 165
x + y = ε, where ε 1/N is a small parameter. In the weak limit (in the distributional sense) ε → 0, the small region x + y ≤ ε, representing the cure state, becomes a single absorbing point where the probability density collapses to a Dirac delta function weighted by the probability of cure before time t, which will henceforth be denoted by p cure (t).
On the boundaries x = 0, ε ≤ y ≤ 1 and y = 0, ε ≤ x ≤ 1, the boundary conditions are both reflecting, Equation (14) is separable with respect to time, i.e., it can be reduced to an eigenvalue problem for the forward Fokker-Planck operator L f defined by recasting Eq. (14) in the formρ( x, t) = L f ρ( x, t). However, it is not separable in the coordinates (x, y) and also depends on these variables explicitly through coefficients inside the differential operators. Finding a basis of two-variable eigenfunctions of L f satisfying the mixed boundary conditions described above is a difficult problem, but unnecessary for our main goal, which is to derive an equation for the recurrence-free survival function S(t), defined as the probability of no-recurrence before time t, i.e.,
where the domain of integration is the region Ω ε = {(x, y)|x ≥ 0; y ≥ 0; ε ≤ x + y ≤ 1} and p rec (t) and p cure (t) are respectively the time-dependent probabilities of recurrence and cure before time t.
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The function S(t) defined in Eq. (16) is a bridge that connects data (survival curves) to the model.
The backward Kolmogorov approach is often more appropriate to first-passage time problems [45] [46] [47] [48] and will be used in combination with Eq. (15) to derive an equation for S(t). The current density derived from the forward equation (Eq. (15)) will be used to derive formulas for the probability flux into the cure state or through the recurrence boundary (note that unlike the forward equation, the backward equation 
Backward Kolmogorov approach
Starting with Eq. (12) and using the adjoint of the master equation operator (6), we can derive the backward Kolmogorov equation by means of a Kramers-Moyal expansion similar to that leading to the forward equation (14) . It should be noted that the differential operators in the backward equation act on functions of the initial-state variables (x 0 , y 0 ):
where L b is the backward operator, (x 01 , x 02 ) ≡ (x 0 , y 0 ), and D ij ( x 0 ) are the components of the diffusion tensor
The backward equation (17) is somewhat different from Eq. (14) in that the non-constant coefficients 185 appear outside the differential operators. It is subject to the final condition that some state x will be reached at time t, starting from anywhere ( x 0 ) in the state space. This explains why the backward equation is often more useful for first-passage time problems than its forward counterpart.
The boundary conditions for the backward equation (17), which can be derived from those of the forward equation (14), are the following. On both absorbing boundaries x 0 + y 0 = ε and x 0 + y 0 = 1, ρ( x, x 0 , t) = 0.
At the reflecting boundaries, the boundary conditions are
at the boundary x 0 = 0, ε ≤ y 0 ≤ 1 and
at the boundary y 0 = 0, ε ≤ x 0 ≤ 1. These boundary conditions are derived in Appendix B.2.
The equations for the probability flux through the absorbing boundaries x+y = 1 and x+y = ε are given in Appendix C. From them, we can derive the partial differential equations below for the time-dependent probabilities of recurrence and cure before time t, respectively (see Appendix C for details):
where L b is the backward operator defined in Eq. (17) and we have used the notation p rec ( x 0 , t), p cure ( x 0 , t)
to recall the dependence on the initial condition x 0 = (x 0 , y 0 ). Since the recurrence-free survival function is 
Function Equation
Boundary
For µ D = 0, we can simplify the backward equation (17) by transforming to the new variables z 0 ≡ x 0 ,
where z ≡ (z, w) and the transformed backward operator is given by
In the new variables (z 0 , w 0 ), the boundary conditions for Eqs. (21), (22), (23) and (24) in Table 1 . The Neumann boundary conditions for Eq. (24) at the boundaries z 0 = 0 and z 0 = w 0 , given in Table 1 , follow immediately from Eqs. (19) and (20), and those for Eqs. (21), (22) and (23) The PDEs (21), (22) and (23), subject to the boundary conditions given in Table 1 , are all separable in 195 time, but not in the initial-state variables (z 0 , w 0 ). However, they can be solved analytically in the large-time limit t → ∞, as will be shown in Section 5.1 below.
A key random variable in our model is the recurrence time (which will be henceforth denoted by T rec ), corresponding to the first passage time through the recurrence boundary. The normalized probability that T rec lies between t and t + dt can be obtained from a simple application of Bayes' theorem [47]:
In other words, the probability density function (PDF) for the recurrence time T rec isṗ rec (t)/p rec (∞) = −Ṡ(t)/p rec (∞), where the probability p rec (∞) =´∞ 0ṗ rec (t)dt that recurrence takes place at any time t < ∞ is given in closed analytic form in Section 5.1 below (see Eq. (32)). The ratio p rec (t)/p rec (∞) then gives 200 the cumulative distribution function (CDF) of T rec .
Let
denote the n-th moment of the recurrence time T rec (n = 0, 1, 2, . . . ). From Eqs. (21) and (27), we get the hierarchy of equations below [44, 45] , where the n-th moment of T rec is related to its (n − 1)-th moment:
Here we have used the notation T (n) rec ( z 0 ) to recall the dependence on the initial condition z 0 . Since the function p rec (∞) also depends on the initial condition through the variable w 0 (see Eq. (32) below), it cannot be taken outside the backward operator L b , because the latter acts on the initial condition variables (z 0 , w 0 ).
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The boundary condition for Eq. (28) at the absorbing boundary w 0 = 1 is T Letting n = 1 in Eq. (28), we get an equation for the mean recurrence time (MRT), denoted here by
This is a key equation in our analysis, which will be used to find an approximate analytical formula for the MRT. 210 
Results and discussion
In this section, we discuss our main results, namely the stationary solution of Eq. shows the effect of a finite detectable-tumor size N on the phase transition.
Stationary solution at large times
The stationary solution of Eq. (21), which satisfiesṗ rec ( z 0 , t) = 0, gives the large-time probability p rec (z 0 , w 0 , ∞) of absorption at the recurrence boundary w = 1, given the initial state (z 0 , w 0 ). In the large-time limit t → ∞, the probability of cure is given by p cure ( z 0 , ∞) = 1 − p rec ( z 0 , ∞): recurrence or cure are the only possible fates at large times. Therefore, p rec (z 0 , w 0 , ∞) satisfies the homogeneous backward equation
where the backward operator in the variables (z 0 , w 0 ) is given by Eq. (25) . The boundary conditions are 220 given in Table 1 .
An ansatz solution to Eq. (30) would be a recurrence probability that only depends on the total initial number of tumor foci w 0 and not specifically on what fraction of this initial number are dormant foci (z 0 ), i.e., ∂ ∂z0 p rec (z 0 , w 0 , ∞) = 0. This type of solution automatically satisfies the Neumann boundary conditions at the reflecting boundaries z 0 = 0 and z 0 = w 0 (see Table 1 ). Using the ansatz above and Eq. (25), the homogeneous PDE (30) becomes the following ODE in the variable w 0 :
where p rec (∞) ≡ p rec (z 0 , w 0 , ∞) only depends on w 0 . This equation can be easily solved for the Dirichlet boundary conditions given in Table 1 . The solution is
where N 0 = w 0 N is the initial total number of tumor foci and
In Eq. (32), the limit ε → 0 has been taken. In the large-time limit t → ∞, the probability of cure is given by
In Fig. 2 , the function (32) is plotted for different values of the detectable tumor size N at a fixed initial number of foci N 0 and also for different initial conditions N 0 at a fixed N .
In the limit N → ∞, this solution displays a phase transition at µ A /λ = 1:
Thus, in the limit N → ∞, the large-time probability of cure for
, which is the large-time limit of the recurrence-free survival function S(t).
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The drift term of the Fokker-Planck equation (14) alone is not sufficient to reproduce the phase transition (35) . The latter is the result of a combination of drift and diffusion in the presence of two opposite absorbing boundaries, so that the initial delta peak ρ( x, 0) = δ( x − x 0 ) splits into a bi-modal probability density ρ( x, t)
with two peaks that travel in opposite directions, toward the cure or recurrence boundaries. For µ A /λ > 1, the height of the peak traveling toward the recurrence boundary vanishes, so the final state in the large-time 230 limit t → ∞ becomes the cure state (0, 0), with probability 1. The result (32) is only slightly different from the stationary solution of the M/M/1/N queue with absorbing boundary states (see Eq. (11)). As we will
show, it agrees with simulations of the discrete-state QBD process.
Approximate solution of the mean recurrence time equation
In this section, we will solve the mean recurence time equation (29) analytically to the leading (zeroth) order in 1/N . This approximation is valid outside boundary layers near the reflecting barriers z 0 = 0 and z 0 = w 0 , the sizes of which vanish as N → ∞. The leading order solution can be obtained by neglecting the second derivative terms in Eq. (29) . This results in the first order PDE which can be solved by the method of characteristics. The solution is
where u is the only root of the transcendental equation
where
and
The procedure for obtaining this solution is described in Appendix D. The finite-N solution of Eq. (29)
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converges to the leading-order approximation given by Eqs. (37) and (38) pointwise, but not uniformly.
Indeed, the approximate solution above does not satisfy the homogeneous Neumann boundary conditions at z 0 = 0 or z 0 = w 0 (see Table 1 ); near each reflecting barrier, there is a boundary layer within which the zeroth-order approximation in 1/N fails. This is seen in the form of the mean recurrence time (MRT) level curves given by Eqs. (37) and (38) , which are straight lines that are not parallel to the recurrence boundary w 0 = 1, except asymptotically in the limit T (1) rec → 0 (see Fig. 3 ). In reality, close to each reflecting barrier (within some distance that vanishes in the limit N → ∞), the exact (finite-N ) level curves bend toward the boundary, where these curves end at a right angle. At fixed initial conditions and as a function of the parameters µ A /λ and ξ/η, the shapes of the MRT level curves given by Eqs. (37) and (38) in parameter space are shown in Fig. 4 for two different initial conditions, namely N 0 = 7, m 0 = 3 and N 0 = 50, m 0 = 20.
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The PDE (29) , along with its boundary conditions given in Table 1 , is a singular perturbation problem that should be handled by special perturbation methods, because the small parameter 1/N premultiplies the second-derivative terms in the backward operator (25) . Further inspection shows that Eq. (29) is structured in such a way that the problem can be treated by boundary-layer theory [49] . Since the solution of Eq. An approximate composite solution that would be valid everywhere can in principle be obtained by the method of matched asymptotic expansions, which requires solving Eq. (29) both inside and outside the boundary layers [49] . In this paper, however, only the leading-order outer solution is given (Eqs. (37) and (38) above). In practice, the outer solution itself is already a quite useful result, even at the lowest order 260 in 1/N , since it agrees reasonably with simulations of the model (as will be shown in Section 5.3 below), except for small corrections that can in principle be calculated using the boundary-layer method.
Simulations
The discrete-state QBD process was simulated for several values of the model parameters and initial conditions using a pseudo random number generator. The results from the simulations were then compared 265 to the large-time stationary solution given by Eq. (32) , and also to outer solution given by Eqs. (37) and (38) . The time step was chosen to be such that the transition probabilities would always remain sufficiently small within the range of the transition rates used in the simulations, even for transitions between states with large numbers m, n ∼ N . For a given set of parameters, each simulation tracked both the fraction of patients for which the tumor recurred and the recurrence times (from which the MRT was estimated) for At the cure state N 0 = 0, the MRT diverges logarithmically and the discrepancy between simulations and the outer solution increases as N 0 approaches zero, due to the boundary-layer structure (the vicinity of the cure state is the region where the boundary layers along the reflecting barriers overlap).
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For both initial conditions N 0 = 7, m 0 = 3 and N 0 = 50, m 0 = 20, Fig. 7 shows the MRT obtained in simulations against the ratio ν ≡ ξ/η at 5 different values of µ A /λ, and compares it to the curves obtained from the leading-order outer solution given by Eqs. (37) and (38) . As expected, the higher the value of µ A /λ, the larger is the discrepancy, since the finite-size effect is greatest near the critical point µ A /λ = 1.
It is worth noting that the ratio ν ≡ ξ/η can in principle be measured in experiments by estimating the 285 relative times that the cells in a tumor spend in dormant versus active phases of the cell cycle, for example, through reconstruction of cell cycle dynamics from single-cell transcriptome data [50] [51] [52] . (38)). We note the logarithmic divergence at the cure state N 0 = 0. the critical point µ A /λ = 1, as shown by Eqs. (37) and (38) . The larger discrepancy near the critical point can be explained by a finite size effect in the phase transition given by Eq. (32) , which effectively shifts the critical point to a value slightly higher than µ A /λ = 1 (see plot in Fig. 2b ).
We note that the continuum limit of the discrete-state master equation is a good approximation, since it agrees reasonably well with the simulations even at leading (zeroth) order in 1/N . This is a remarkable 295 feature of our model, since the diffusion limit sometimes fails for other types of birth-and-death processes, especially ones that involve non-linear transition rates [53].
Fitting the model to survival data
Even in the context of univariate birth-and-death processes, estimating model parameters from data is generally a difficult problem [55] . In this section, we describe a simple procedure to fit the model to survival 300 data through an example. Since the method that we describe below relies on the leading-order outer solution given by Eqs. (37) and (38) , it is approximately valid (within O(1/N ) corrections) for initial conditions outside the boundary layers.
Serous ovarian cancer data downloaded from the public database The Cancer Genome Atlas [54] (TCGA) were used to generate the recurrence-free survival function shown in Fig. 9 . Since 170 out of the 583 patients 305 in the data set were censored, the Kaplan-Meier product-limit estimator [56] was used to estimate the timedependent probability of no recurrence.
In order to obtain the MRT from a given survival function S(t), we first need to renormalize the probability of recurrence p rec (t) = 1 − S(t) as in Eq. (26), i.e., the appropriate probability measure is conditioned on recurrence. The renormalized survival functionS(t) is then given bỹ
which vanishes in the limit t → ∞. The MRT is then given by the area under the curveS(t), i.e., T
For the serous ovarian cancer data from TCGA, we found S(∞) = 0.086 (defined as the lowest value of the Kaplan-Meier estimate for S(t)) and an MRT of 687.5 days. For a given initial condition, T (1) rec = 17.2/λ) and the inferred µ A /λ. This is done by solving Eqs. (37) and (37) numerically for ν ≡ ξ/η (see also Eq. (2)).
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Using the parameters determined through the scheme described above, survival curves were simulated for several initial conditions N 0 . In Fig. 10 , these curves are shown in one plot, along with the Kaplan-Meier curve for the ovarian cancer data from TCGA. The time axis was rescaled to units of the MRT and the values of N 0 , µ A /λ and ν ≡ ξ/η used in the simulations are given in the legend. Among the initial conditions shown in the plot, the best fit corresponds to the choice N 0 = 45.
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In this procedure for fitting the model to data, we have assumed a sharply peaked initial condition, i.e., the initial condition is a delta function centered at some specified initial number of tumor foci N 0 .
However, in reality this number should follow a probability distribution that would reflect the histogram of the residual-tumor size in the population under study. Moreover, different patients may have different responses to treatment (i.e., different values of µ A /λ), as well as different ξ/η values. This means that the were fixed using the scheme described in Section 5.4, which ensures that the MRT and the large-time recurrence probability both match the data. Among the initial conditions shown in the plot, the best fit (thick blue curve) corresponds to the choice N 0 = 45.
Conclusion
In this paper, we developed a mechanistic mathematical model aimed at describing the stochastic dy- Using the forward and backward Kolmogorov approaches in the continuum limit, we derived an equation
for the time-dependent probability of recurrence and the appropriate boundary conditions. The stationary solution at large times was then obtained analytically (see Eq. (32)) and we showed that it displays a phase (where the variables have to be rescaled) and constructing a composite solution by the method of matched asymptotic expansions [49] .
Finally, we described a scheme to fit the model to recurrence-free survival data (Kaplan-Meier curves), using ovarian cancer data from TCGA [54] as an example (Fig. 10) . The model has potential applications to predicting the effect of changes in the tumor death rate or in the duration of chemotherapy on survival 360 (recurrence rates). By switching the parameter µ A at a specified time t = t chemo (where t chemo represents the duration of chemotherapy) from some specified level µ chemo to a lower baseline level µ 0 , we can simulate the effect on survival of extending chemotherapy at lower dose (i.e., simultaneously increasing t chemo and lowering µ chemo ). This would allow quantitative studies of the effect of changes in chemotherapy regimens that can potentially be useful as a guide to clinical practice.
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Projecting the operatorQ =Q bulk +Q edge given by Eqs. (6) and (7) on both sides between basis vectors m, n| and |m , n , we get matrix elements with a block-tridiagonal structure in the direct-product linear space D ⊗ A:
From the geometry of the state space boundary (see Fig. 1b ), it follows that the block matrices Q mm decrease in size as m increases: Q mm is an (N − m + 1) × (N − m + 1) matrix, since only the subspace spanned by the states |m, 0 , . . . , |m, N − m is accessible. The bulk part of each block Q mm is tridiagonal and acts within the accessible subspace of A:
The bulk parts of the off-diagonal blocks are the matrices Q bulk m,m+1 = (m + 1)
The edge corrections for the three block matrices above are given by 
where ρ reg ( x, t) is the regular part of ρ( x, t) and p cure (t) is the probability of cure at any time ≤ t. In Section 4.2, it is shown that this boundary condition can be fixed through an equation for the function p cure (t) (see Eq. (22)), which is derived using the backward Kolmogorov approach. In Section 5.1, the large-time limit is integrated over this area, we get exactly p cure (t), i.e., the small region near the origin approximately represents the cure state. In the weak limit (in distributional sense) ε → 0, the probability density at the origin becomes a Dirac delta distribution.
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The boundary condition at the recurrence line x + y = 1 is also absorbing, i.e., ρ( x, t) = 0. At either x = 0 or y = 0, the boundary condition for the regular part of J( x, t) (i.e., the current density defined by Eq.
(15), corresponding to the regular part of ρ( x, t)) is given by J reg ( x, t)· n = 0, where n is the outward normal, i.e., there cannot be any flux crossing the boundaries x = 0 or y = 0, except at the cure state (x, y) = (0, 0), at which the regular part of ρ( x, t) vanishes, whereas the delta peak works as a single absorbing point.
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The absorbing boundary conditions should be interpreted as follows: while the single absorbing point at the origin pins any probability that it absorbs to the cure state (thus the delta peak), the probability flux through the recurrence boundary x + y = 1 exits to the outer region {(x, y)|x ≥ 0; y ≥ 0; x + y ≥ 1} and never returns.
This proper definition of the boundary condition near the origin ensures that the Fokker-Planck equation (14) gives the correct probability conservation equation in its integral form. Indeed, using the boundarycondition scheme described above and integrating Eq. where D is the diffusion tensor defined in Eq. (18) .
Since the backward operator is the adjoint of the forward operator, i.e., L b = L † f , we must have L f f, g = f, L b g for any square-integrable functions f, g defined on the domain Ω ε that satisfy the forward and backward equation/boundary conditions, respectively. Therefore, it follows that the boundary term on the right-hand side of Eq. (B.6) must vanish for any such f, g. This means that given boundary conditions on any function f satisfying the forward equation, the boundary conditions for any function g satisfying the backward equation have to be chosen in such a way that the integrand on the second term of Eq. (B.6) must vanish. It then follows that g = 0 for absorbing boundaries and (D ∇g) · n = 0 for reflecting boundaries.
Hence, on both absorbing boundaries x 0 + y 0 = ε and x 0 + y 0 = 1, the boundary condition is ρ( x, x 0 , t) = 0. where S( x 0 , t) is the recurrence-free survival function (see Eqs. (16) and (B.4)) andṗ rec ( x 0 , t) ≡ ∂ ∂t p rec ( x 0 , t). For µ D = 0, using the boundary condition that the probability density has to vanish at the recurrence line
x + y = 1, we getṗ The partial differential equations (21) and (22) 
rec (here we can choose the constant of integration to be zero, since it can be absorbed into the constants s 1 and s 2 in Eqs. (D.2) below).
